SCHEMBL24693261

SCHEMBL24693261

C=CCNCCc1c[nH]c2ccc(F)cc12

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MPO P05164 14/20 0.69
SLC6A4 P31645 4/20 0.67
HTR2A P28223 2/20 0.64
HTR1A P08908 2/20 0.64
ADRA2A P08913 1/20 0.64
DRD2 P14416 1/20 0.64
ADRA2B P18089 1/20 0.64
ADRA2C P18825 1/20 0.64
SLC6A2 P23975 1/20 0.64
HTR1D P28221 1/20 0.64
HTR1B P28222 1/20 0.64
HTR2C P28335 1/20 0.64
HTR1E P28566 1/20 0.64
HTR7 P34969 1/20 0.64
ADRA1A P35348 1/20 0.64
HRH1 P35367 1/20 0.64
DRD3 P35462 1/20 0.64
OPRK1 P41145 1/20 0.64
HTR2B P41595 1/20 0.64
HTR5A P47898 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25076863 0.84 HTR2C (0.64) SLC6A4HTR2AHTR1AHTR1DHTR1B
SCHEMBL2405001 0.82 MPO (1.00) MPOSLC6A4HTR2AHTR1ANOTUM
SCHEMBL24693250 0.81 SLC6A4 (0.68) MPOSLC6A4HTR2AHTR1AADRA2A
SCHEMBL2403826 0.81 MPO (1.00) MPOSLC6A4HTR2AHTR1AHTR1D
SCHEMBL30877882 0.81 MPO (0.68) MPOSLC6A4HTR2AHTR1ANOTUM
SCHEMBL2407287 0.81 MPO (1.00) MPOSLC6A4HTR2AHTR1ANOTUM
SCHEMBL27210131 0.81 MPO (0.68) MPOSLC6A4HTR2AHTR1ANOTUM
SCHEMBL30412581 0.81 HTR2A (0.73) MPOSLC6A4HTR2AHTR1AADRA2A
SCHEMBL30094716 0.80 MC5R (0.68) MPOSLC6A4HTR2AHTR1AADRA2A
SCHEMBL10671627 0.80 MC5R (0.68) MPOSLC6A4HTR2AHTR1AADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117957211-A Fluorinated tryptamine compounds, analogs thereof, and methods of use thereof 圣约瑟夫大学 2024-04-30 CN claimed
US-20240286998-A1 FLUORINATED TRYPTAMINE COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME SAINT JOSEPH'S UNIVERSITY 2024-08-29 US disclosed
CN-117957211-A Fluorinated tryptamine compounds, analogs thereof, and methods of use thereof 圣约瑟夫大学 2024-04-30 CN disclosed
WO-2022256554-A1 FLUORINATED TRYPTAMINE COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME UNIVERSITY OF THE SCIENCES (US) 2022-12-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240286998-A1 FLUORINATED TRYPTAMINE COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME TPH2, TPH1, HNMT MPO 1666/4885SLC6A4 17/4885HTR2A 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.